Mirae Asset Global Investments’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-28,822
| Closed | -$629K | – | 2521 |
|
|
2024
Q1 | $629K | Buy |
28,822
+1,135
| +4% | +$24.8K | ﹤0.01% | 1795 |
|
|
2023
Q4 | $603K | Sell |
27,687
-1,540
| -5% | -$33.5K | ﹤0.01% | 1880 |
|
|
2023
Q3 | $448K | Buy |
29,227
+4,412
| +18% | +$67.7K | ﹤0.01% | 1937 |
|
|
2023
Q2 | $592K | Buy |
24,815
+1,645
| +7% | +$39.2K | ﹤0.01% | 1864 |
|
|
2023
Q1 | $589K | Buy |
23,170
+6,702
| +41% | +$170K | ﹤0.01% | 1843 |
|
|
2022
Q4 | $481K | Buy |
16,468
+5,856
| +55% | +$171K | ﹤0.01% | 1917 |
|
|
2022
Q3 | $218K | Buy |
+10,612
| New | +$218K | ﹤0.01% | 2308 |
|